Dexcom (DXCM) Inventory Average (2011 - 2026)

Dexcom (DXCM) has 16 years of Inventory Average data on file, last reported at $661.4 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $661.4 million, up 22.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $661.4 million (up 22.38% YoY), and the FY2025 annual result was $585.8 million, up 6.31% from the prior year.
• Inventory Average grew to $661.4 million in Q1 2026 per DXCM's latest filing, from $616.6 million in the prior quarter.
• Over five years, Inventory Average peaked at $661.4 million in Q1 2026 and troughed at $308.8 million in Q4 2022.
• A 5-year average of $488.3 million and a median of $540.4 million in 2025 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2023: Inventory Average dropped 12.83% in 2022, then surged 71.31% in 2023.
• A 5-year view of Inventory Average shows it stood at $308.8 million in 2022, then surged by 71.31% to $529.1 million in 2023, then advanced by 6.68% to $564.4 million in 2024, then rose by 9.24% to $616.6 million in 2025, then increased by 7.26% to $661.4 million in 2026.
• Business Quant data shows DXCM's Inventory Average at $661.4 million in Q1 2026, $616.6 million in Q4 2025, and $587.4 million in Q3 2025.